Patents
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
04/2011
04/06/2011EP1404324B2 Prodrugs of gaba analogs, compositions and uses thereof
04/06/2011EP1370277B1 Use of oxytocin for the preparation of a pharmaceutical composition against cancer in situ and cervicitis
04/06/2011EP1255556B1 Neuroprotective, antithrombotic and anti-inflammatory uses of activated protein c (apc)
04/06/2011CN1981869B Compound non-carrier antibacterial eye drops containing practofren and its production
04/06/2011CN1762495B Long acting sustained-release formulation containing dopamine-receptor stimulant medicine and its preparation process
04/06/2011CN1376146B Solid-state form of celecoxil having enhanced bioavailability
04/06/2011CN102006891A Continuous cell programming devices
04/06/2011CN102006889A Topical combinations comprising an antimycotic agent and an antiviral agent
04/06/2011CN102006882A Treating neurodegenerative diseases with progranulin (pgrn)
04/06/2011CN102006867A Oral pharmaceutical suspension comprising paracetamol and ibuprofen
04/06/2011CN102002096A Amphipathic compound using somatostatin analogue as target radical and pharmaceutics application thereof
04/06/2011CN102000341A Polyethylene oxide and matrix type surfactant in suppository composition
04/06/2011CN102000337A Prescription for treating foot odor
04/06/2011CN102000336A Carbostyril derivatives and mood stabilizers for treating mood disorders
04/06/2011CN102000335A Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
04/06/2011CN102000334A Compound preparation for treating depression
04/06/2011CN102000178A Method and plaster for treating scalds and burns through combining traditional Chinese medicine with western medicine
04/06/2011CN101420989B Polymer NO donor predrug nanofiber coating for medical devices and therapy
04/06/2011CN101262861B Pharmaceutical for use in prevention and/or treatment of bowel disease
04/06/2011CN101152164B Anti-cicatrix externally used pad pasting containing anti-hypertrophy cell medicament and method for preparing the same
04/06/2011CN101011575B RNA interference medicament for preventing and treating atherosclerosis
04/05/2011WO2010045415A2 Topical nsaid compositions having sensate component
04/05/2011US7919614 Synthetic polysaccharides, process for their preparation and pharmaceutical compositions containing them
04/05/2011US7919588 Netrin receptors
04/05/2011US7919524 Compounds, compositions and methods
04/05/2011US7919477 Multiple CpG oligodeoxynucleotides and their use to induce an immune response
04/05/2011US7919459 Cardiovascular disorders; antidiabetic agents; respiratory system disorders; antagonist of protein g receptor
04/05/2011US7919329 Method for screening for agents that affect food intake
04/05/2011US7919123 Composition and method for treating or preventing gastrointestinal cancer
04/05/2011US7919091 Lipolysis stimulated receptor (LSR) specific antibodies
04/05/2011US7919085 Using secretory carrier membrane protein 5 protein specific monoclonal antibody as diagnostic tool in screening for cutaneous t-cell lymphomas (CTCL)
04/05/2011CA2739682A1 Topical nsaid compositions having sensate component
04/05/2011CA2514681C Methods and compositions for inhibition of angiogenesis
04/05/2011CA2461703C Modulation of physiological processes and agents useful for same
04/05/2011CA2447909C Use of proteasome inhibitors to treat dry eye disorders
04/05/2011CA2425638C Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
03/2011
03/31/2011WO2011037467A1 Atazanavir for treating inflammatory diseases
03/31/2011WO2011036879A1 Transferrin liposome preparation
03/31/2011WO2011036202A1 Retinal neuroprotection by ion channel blockers regulated by the sur subunit
03/31/2011WO2011036047A1 Pharmaceutical composition for the treatment of mcp-1 mediated inflammatory diseases
03/31/2011WO2010119424A3 Composition for regulating the metabolism of lipids
03/31/2011US20110077217 Selectively depolymerized galactomannan polysaccharide
03/31/2011US20110076295 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
03/31/2011US20110076286 Methods of inhibiting unwanted cell proliferation using hedgehog antagonists
03/31/2011CA2775039A1 Retinal neuroprotection by ion channel blockers regulated by the sur subunit
03/31/2011CA2760180A1 Pharmaceutical composition for the treatment of mcp-1 mediated inflammatory diseases
03/30/2011EP2301952A2 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
03/30/2011EP2301628A1 Methods and reagents for the treatment of immunoinflammatory disorders
03/30/2011EP2301579A1 Therapeutic method for reducing angiogenesis
03/30/2011EP2301578A2 Methods for treating TWEAK-related conditions
03/30/2011EP2301577A2 Methods for treating TWEAK-related conditions
03/30/2011EP2301567A1 Selective immune down regulation (SIDR) for transplantation
03/30/2011EP2301565A1 Use of proteasome inhibitors for the treatment of viral infections
03/30/2011EP2301563A2 HSP20 peptides
03/30/2011EP2301562A1 Irrigation solution and method for inhibition of pain, inflammation and spasm
03/30/2011EP2301556A1 Co-Administration of a Polysaccharide with a Chemotherapeutic Agent for the Treatment of Cancer
03/30/2011EP2301551A1 Use of alkyl phosphocholines in combination with antitumor medicaments
03/30/2011EP2301549A1 Remedies for diseases to be applied to eye
03/30/2011EP2301541A1 Antibiotic compositions for treatment of the eye, ear and nose
03/30/2011EP2301537A1 Zonisamide for the treatment of obesity
03/30/2011EP2301356A2 Rapid one-step method for generation of antigen loaded dendritic cell vaccine from precursors
03/30/2011EP2300055A1 Anticancer combination therapy including triciribine
03/30/2011EP2300023A2 Microorganisms for preventing and treating neoplasms accompanying cellular therapy
03/30/2011EP2300020A2 Nutritive compositions and methods of using same
03/30/2011EP2300014A1 Use of pyrimidylaminobenzamide derivatives for the treatment of fibrosis
03/30/2011EP2300006A1 Colon cleansing method and kit
03/30/2011EP2300004A2 Compositions and methods relating to heat shock transcription factor activating compounds and targets thereof
03/30/2011EP2300003A2 Methods for treating injury associated with exposure to an alkylating species
03/30/2011EP2299991A1 A method for increasing bone density and/or reducing any osteochondral defects in an animal and a composition including vitamin k
03/30/2011EP2299822A2 Method for treating neurodegenerative dysfunction
03/30/2011EP2299810A1 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
03/30/2011EP2178513B1 Tableted compositions containing atazanavir
03/30/2011EP1838392B1 Selenium-containing medicaments for the prevention or treatment of endothelial vascular diseases
03/30/2011EP1558586B1 Inhibitors of akt activity
03/30/2011EP1317485B1 Myostatin antagonists and uses thereof
03/30/2011EP1305007B1 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
03/30/2011EP1053023B2 Systemic delivery of serum stable plasmid lipid particles for cancer therapy
03/30/2011CN101998865A Combined treatment with an EGFR kinase inhibitor and an inhibitor of C-KIT
03/30/2011CN101998864A 调节t细胞依赖性免疫应答的方法 The method of regulating cell-dependent immune response t
03/30/2011CN101998859A Pharmaceutical composition for preventing dysbiosis associated with enteral administration of antibiotics
03/30/2011CN101998858A Pharmaceutical composition of antibiotics and prebiotics for preventing and treating dysbiosis during antibacterial therapy
03/30/2011CN101991854A Novel blood fat-lowering composition
03/30/2011CN101991853A Statin magnesium-containing blood lipid lowering composition
03/30/2011CN101991852A Application of miR-494 inhibitor in preparing preparation for resisting bone calcium loss and promoting bone formation
03/30/2011CN101991851A Ultrasound microbubble agent for treating tumors by low-intensity focused ultrasound and preparation method thereof
03/30/2011CN101991563A Tooth sensitivity treatment compositions
03/30/2011CN101991562A Tooth sensitivity treatment compositions
03/30/2011CN101045163B High molecular anticarcinogenic prodrug, its preparing method and use
03/29/2011US7915317 substantially free of glyceryl esters of medium or long chain fatty acids; propofol red blood cell-blood plasma partition coefficient, Kp, for the composition is at least about twice the Kp obtained upon administration of a conventional propofol emulsion under the same delivery conditions
03/29/2011US7915312 Topical application to the eye of an acetylcholinesterase inhibitor such as echothiophate iodide to treat color blindness, ocular hypertension and glaucoma, and progression of myopia Strabismus Stargardts or pupil dilation.
03/29/2011US7915291 Hepatitis C virus inhibitors
03/29/2011US7915265 Combinations for the treatment of immunoinflammatory disorders
03/29/2011US7915264 Drugs for treating pain formed by arylation
03/29/2011US7915234 Pharmaceutically active uridine esters
03/29/2011US7915232 4′-substituted nucleoside derivatives as inhibitors of HCV RNA replication
03/29/2011US7915226 Methods of suppressing microglial activation
03/29/2011US7915219 treatment of cell damage caused by ischemia or stroke by administering to a cell or a tissue an effective amount of an isozyme specific delta PKC (protein kinase C) antagonist
03/29/2011US7915009 Modulating NF-kappa B by administering antigens or polynucleotide encoding antigens, antibody; treating cancer, tumor, Alzheimer's disease or a spongiform encephalopathy; DNA vaccine in kits
03/29/2011US7914831 Alpha acids, isoalpha acids, reduced isoalpha acids, tetra-hydroisoalpha acids, hexa-hydroisoalpha acids, beta acids from hops; nontoxic
03/29/2011US7914823 Method and composition for the topical treatment of diabetic neuropathy